Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ENTL
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Bragg Gaming Group Reports First Quarter 2026 Financial Results
TORONTO, May 14, 2026--(BUSINESS WIRE)--Bragg Gaming Group (NASDAQ:BRAG; TSX:BRAG) ("bragg" or the "Company"), a leading igaming content and platform technology solutions provider, today announced its financial results for the first quarte…
Bragg Gaming Further Extends PAM Agreement with Entain
TORONTO, January 09, 2026--(BUSINESS WIRE)--Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) ("Bragg" or the "Company"), a global iGaming content and technology supplier, is pleased to announce the extension of its existing Player Account Mana…
MARLTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the election of five new members to its Board of Directors at the most re…
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers
MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity for nasal airway obstruction (NAO) patients…
Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction
PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon dilation with ongoing medical therapy for the tr…
Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA
MENLO PARK, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced the publication of positive data from prospective, multicenter OR and Office studies of LATERA for patients with symptoms o…
New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atara Biotherapeutics…
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash
PLYMOUTH, Minn., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) announced today a definitive merger agreement by which Stryker Corporation (NYSE:SYK) will acquire Entellus in an all cash transaction for $24.00 per s…
Stryker announces definitive agreement to acquire Entellus
Kalamazoo, Michigan - December 7, 2017 - Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of approximately $662 million.…
Entellus Medical to Participate in Upcoming Investor Conferences
PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to participate in two upcoming…
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation
PLYMOUTH, Minn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that Anthem, Inc. now covers balloon sinus dilat…
Entellus Medical Announces Third Quarter 2017 Financial Results
PLYMOUTH, Minn., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering less invasive ENT products, today reported its financial results for the quarter ended September 30…
Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®
PLYMOUTH, Minn., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) today announced data from its first-in-human study of the Latera® absorbable nasal implant from Spirox®. The 18 and 24-month data demonstrate that pati…
Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017
PLYMOUTH, Minn., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it will release financial results for the t…
Entellus Medical Announces New Employee Inducement Option Grants
PLYMOUTH, Minn., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that the Compensation Committee of the Board of…
Entellus Medical Announces Second Quarter 2017 Financial Results
PLYMOUTH, Minn., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical to Present at the Canaccord Genuity Annual Growth Conference
PLYMOUTH, Minn., July 26, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the less invasive treatmen…
Entellus Medical to Report Second Quarter 2017 Financial Results August 3, 2017
PLYMOUTH, Minn., July 20, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for less invasive treatment of…
Entellus Medical Announces Definitive Agreement to Acquire Spirox
Acquisition Adds Innovative and Minimally Invasive Treatment For Nasal Airway Obstruction – Significantly Expanding Office and Operating Room Based ENT Opportunities Announces Preliminary Second Quarter 2017 Revenue Results and Updates 201…
Entellus Medical to Present at the William Blair Growth Stock Conference
PLYMOUTH, Minn., June 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
The Centers for Medicare & Medicaid Services (CMS) Establishes Coding and Payment for Eustachian Tube Balloon Dilation
PLYMOUTH, Minn., May 22, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive trea…
Entellus Medical Announces First Quarter 2017 Financial Results
PLYMOUTH, Minn., May 03, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical to Present at the Deutsche Bank Annual Health Care Conference
PLYMOUTH, Minn., April 20, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tr…
Entellus Medical to Report First Quarter 2017 Financial Results on May 3, 2017
PLYMOUTH, MN, April 19, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treat…
Entellus Medical Receives FDA 510(k) Clearance for Eustachian Tube Indication
PLYMOUTH, Minn., April 12, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tr…
Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
PLYMOUTH, Minn., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 21, 2017
Conference call scheduled for Tuesday, February 21, 2017 at 3:30pm CT / 4:30pm ET PLYMOUTH, Minn., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient…
Entellus Medical Announces Pricing of Public Offering of Common Stock
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products d…
Entellus Medical Announces Proposed Public Offering of Common Stock
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products d…
Entellus Medical Announces Management Promotions and Preliminary Revenue for Fourth Quarter and Full Year 2016
PLYMOUTH, Minn., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
National Institute for Health and Care Excellence (NICE) Provides Positive Guidance for Use of the XprESS Multi-Sinus Dilation System for Treating Chronic Sinusitis
PLYMOUTH, Minn., Dec. 13, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical Announces Publication of Positive Clinical Data for XprESS for Treatment of Pediatric Chronic Rhinosinusitis
PLYMOUTH, Minn., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical to Present at the Piper Jaffray Healthcare Conference
PLYMOUTH, Minn., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical Announces Third Quarter 2016 Financial Results
PLYMOUTH, Minn., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Entellus Medical to Report Third Quarter 2016 Financial Results on November 3, 2016
PLYMOUTH, Minn., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive tre…
Helius Medical Technologies Appoints Thomas Griffin to Board of Directors and Chairman of the Audit Committee
NEWTOWN, PENNSYLVANIA--(Marketwired - Aug. 8, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company") a company focused on the treatment of neurological symptoms caused by disease or trauma, announced to…